Search by Drug Name or NDC

    NDC 00527-4068-37 TRIENTINE HYDROCHLORIDE 250 mg/1 Details

    TRIENTINE HYDROCHLORIDE 250 mg/1

    TRIENTINE HYDROCHLORIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company Inc.. The primary component is TRIENTINE HYDROCHLORIDE.

    Product Information

    NDC 00527-4068
    Product ID 0527-4068_0090a2e0-927a-4284-a88b-b3c4cb7dbbdb
    Associated GPIs 99200020100110
    GCN Sequence Number 002554
    GCN Sequence Number Description trientine HCl CAPSULE 250 MG ORAL
    HIC3 C8A
    HIC3 Description METALLIC POISON,AGENTS TO TREAT
    GCN 00720
    HICL Sequence Number 001109
    HICL Sequence Number Description TRIENTINE HCL
    Brand/Generic Generic
    Proprietary Name TRIENTINE HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name TRIENTINE HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name TRIENTINE HYDROCHLORIDE
    Labeler Name Lannett Company Inc.
    Pharmaceutical Class Metal Chelating Activity [MoA], Metal Chelator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211251
    Listing Certified Through 2024-12-31

    Package

    NDC 00527-4068-37 (00527406837)

    NDC Package Code 0527-4068-37
    Billing NDC 00527406837
    Package 1 BOTTLE in 1 CARTON (0527-4068-37) / 100 CAPSULE in 1 BOTTLE
    Marketing Start Date 2020-12-22
    NDC Exclude Flag N
    Pricing Information N/A